{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T21:30:57Z","timestamp":1792099857959,"version":"4.4.0"},"reference-count":35,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,9,25]],"date-time":"2023-09-25T00:00:00Z","timestamp":1695600000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:p>Small cell cancer (SCC) is a neuroendocrine neoplasm, which is most frequently found in the lungs. Extrapulmonary location of SCC is rare and may involve 2.5-5% of SCCs. We present a case of a 31-year-old male patient with an extremely uncommon subglottic SCC. The patient was qualified for a radical sequential chemoradiotherapy. After treatment, patient\u2019s condition suggested complete remission. Recurrence was detected one year later, and the disease rapidly progressed, despite a second line chemotherapy. The patient died 29 months after initial diagnosis. This case aims to raise awareness on the aggressive laryngeal SCC and its good response to first line chemotherapy composed of cisplatin and etoposide, followed by radiotherapy.<\/jats:p>","DOI":"10.3389\/fonc.2023.1222418","type":"journal-article","created":{"date-parts":[[2023,9,26]],"date-time":"2023-09-26T05:02:11Z","timestamp":1695704531000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":7,"title":["Small cell carcinoma with neuroendocrine differentiation of subglottic larynx- a case report"],"prefix":"10.3389","volume":"13","author":[{"given":"Rafa\u0142","family":"Becht","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kajetan","family":"Kie\u0142bowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justyna","family":"\u017bychowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wiktoria","family":"Dembowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ma\u0142gorzata","family":"Kr\u00f3l","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo\u017cena","family":"Birkenfeld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mateusz","family":"Owsiak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magdalena","family":"Lewandowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jadwiga","family":"Kubrak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katarzyna","family":"Amernik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,9,25]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1053\/j.seminoncol.2006.10.027","article-title":"Small cell carcinoma of unknown primary","volume":"34","author":"Lobins","year":"2007","journal-title":"Semin Oncol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1053\/j.seminoncol.2006.11.017","article-title":"The pathology of extrapulmonary small cell carcinoma","volume":"34","author":"Frazier","year":"2007","journal-title":"Semin Oncol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1186\/1471-2407-9-209","article-title":"The epidemiology and survival of extrapulmonary small cell carcinoma in South East England, 1970-2004","volume":"9","author":"Wong","year":"2009","journal-title":"BMC Cancer"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejso.2020.04.017","article-title":"Extrapulmonary small cell carcinoma: Prognostic factors, patterns of care, and overall survival","volume":"46","author":"Mandish","year":"2020","journal-title":"Eur J Surg Oncol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.oraloncology.2017.04.009","article-title":"Small cell carcinoma of the head and neck: An analysis of the National Cancer Database","volume":"69","author":"Pointer","year":"2017","journal-title":"Oral Oncol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1159\/000072249","article-title":"Small cell neuroendocrine carcinoma of the larynx: A preventable and frustrating disease with a highly aggressive lethal behavior","volume":"65","author":"Ferlito","year":"2003","journal-title":"ORL"},{"key":"B7","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/s12105-017-0788-z","article-title":"Update from the 4th edition of the world health organization classification of head and neck tumours: what is new in the 2017 WHO blue book for tumours of the hypopharynx, larynx, trachea and parapharyngeal space","volume":"11","author":"Gale","year":"2017","journal-title":"Head Neck Pathol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.11105","article-title":"A 5-decade analysis of 13,715 carcinoid tumors","volume":"97","author":"Modlin","year":"2003","journal-title":"Cancer"},{"key":"B9","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1038\/s41572-020-00235-0","article-title":"Small-cell lung cancer","volume":"7","author":"Rudin","year":"2021","journal-title":"Nat Rev Dis Primers"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.22887","article-title":"Extrapulmonary small-cell carcinoma compared with small-cell lung carcinoma: A retrospective single-center study","volume":"110","author":"Cicin","year":"2007","journal-title":"Cancer"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.poamed.2016.06.003","article-title":"The small cell carcinoma neuroendocrine type of the larynx\u2014Case report","volume":"24","author":"Pytal","year":"2017","journal-title":"Polish Ann Med"},{"key":"B12","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1097\/MPA.0b013e3181ebb56f","article-title":"The NANETS consensus guidelines for the diagnosis and management of poorly differentiated (High-Grade) extrapulmonary neuroendocrine carcinomas","volume":"39","author":"Strosberg","year":"2010","journal-title":"Pancreas"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1097\/PAP.0000000000000147","article-title":"Differential diagnosis in neuroendocrine neoplasms of the larynx","volume":"24","author":"Hunt","year":"2017","journal-title":"Adv Anat Pathol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"153567","DOI":"10.1016\/j.prp.2021.153567","article-title":"CD56 expression in multiple myeloma: Correlation with poor prognostic markers but no effect on outcome","volume":"225","author":"Koumpis","year":"2021","journal-title":"Pathol Res Pract"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1136\/jcp.2004.023044","article-title":"CD56: A useful tool for the diagnosis of small cell lung carcinomas on biopsies with extensive crush artefact","volume":"58","author":"Kontogianni","year":"2005","journal-title":"J Clin Pathol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.4251\/wjgo.v3.i10.144","article-title":"TTF-1 positive small cell cancers: Don\u2019t think they\u2019re always primary pulmonary","volume":"3","author":"Verset","year":"2011","journal-title":"World J Gastrointest Oncol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2020.00228","article-title":"TTF-1 positive primary small cell carcinoma of the breast: A case report and review of the literature","volume":"11","author":"Boutrid","year":"2020","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B18","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s40425-018-0359-1","article-title":"Immunohistochemical expression and prognostic value of PD-L1 in Extrapulmonary small cell carcinoma: A single institution experience","volume":"6","author":"Salhab","year":"2018","journal-title":"J Immunother Cancer"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.2017.44","article-title":"FOXA2 is a sensitive and specific marker for small cell neuroendocrine carcinoma of the prostate","volume":"30","author":"Park","year":"2017","journal-title":"Modern Pathol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1186\/s43163-022-00337-4","article-title":"A rare localization of small-cell carcinoma in head and neck area: case report","volume":"38","author":"Ni","year":"2022","journal-title":"Egyptian J Otolaryngol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2021.03.207","article-title":"Small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up\u2606;","volume":"32","author":"Dingemans","year":"2021","journal-title":"Ann Oncol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1002\/hed.23666","article-title":"Clinical recommendations on the treatment of neuroendocrine carcinoma of the larynx: A meta-analysis of 436 reported cases","volume":"37","author":"Van Der Laan","year":"2015","journal-title":"Head Neck"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1002\/ccr3.2545","article-title":"Head and neck neuroendocrine tumors at a single institution over 15 years","volume":"7","author":"Bacalao","year":"2019","journal-title":"Clin Case Rep"},{"key":"B24","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s12070-015-0866-z","article-title":"Small-cell neuroendocrine tumor of larynx: A rare presentation","volume":"71","author":"Pavan Kumar","year":"2019","journal-title":"Indian J Otolaryngol Head Neck Surg"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.2147\/OTT.S173231","article-title":"Successful cisplatin-etoposide chemotherapy-based treatment of a primary small cell neuroendocrine carcinoma of the tonsil with multiple metastases: A case report","volume":"11","author":"Wang","year":"2018","journal-title":"Onco Targets Ther"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1177\/10732748221087075","article-title":"Clinical characteristics and prognosis of small cell carcinoma in the nasopharynx: A population-based study","volume":"29","author":"Zhou","year":"2022","journal-title":"Cancer Control"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/j.amsu.2018.04.031","article-title":"Primary small cell carcinoma of the larynx. Survival time of 47 months","volume":"30","author":"Raposo","year":"2018","journal-title":"Case Rep Ann Med Surg"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1017\/S0022215115001668","article-title":"Small cell neuroendocrine carcinoma of larynx: Case series and literature review","volume":"129","author":"Iqbal","year":"2015","journal-title":"J Laryngology Otology"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1159\/000276220","article-title":"Small cell neuroendocrine carcinoma of the larynx A critical review of the literature","volume":"53","author":"Gnepp","year":"1991","journal-title":"ORL J Otorhinolaryngol Relat Spec"},{"key":"B30","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.ctrv.2019.08.002","article-title":"Small cell and large cell neuroendocrine carcinoma of the larynx: A comparative analysis","volume":"78","author":"Strojan","year":"2019","journal-title":"Cancer Treat Rev"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.23327","article-title":"Sore throat: can it be primary laryngeal small cell carcinoma","volume":"14","author":"Naqvi","year":"2022","journal-title":"Cureus"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1056\/nejmoa1809064","article-title":"First-line atezolizumab plus chemotherapy in extensive-stage small-cell lung cancer","volume":"379","author":"Horn","year":"2018","journal-title":"New Engl J Med"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1177\/23247096221127792","article-title":"Small cell neuroendocrine of the head and neck: A rare presentation and review of the literature","volume":"10","author":"Niforatos","year":"2022","journal-title":"J Investig Med High Impact Case Rep"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(19)32222-6","article-title":"Durvalumab plus platinum\u2013etoposide versus platinum\u2013etoposide in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): a randomised, controlled, open-label, phase 3 trial","volume":"394","author":"Paz-Ares","year":"2019","journal-title":"Lancet"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.20.00793","article-title":"Pembrolizumab or placebo plus etoposide and platinum as first-line therapy for extensive-stage small-cell lung cancer: randomized, double-blind, phase III KEYNOTE-604 study","volume":"38","author":"Rudin","year":"2020","journal-title":"J Clin Oncol"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2023.1222418\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,26]],"date-time":"2023-09-26T05:02:12Z","timestamp":1695704532000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2023.1222418\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,25]]},"references-count":35,"alternative-id":["10.3389\/fonc.2023.1222418"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2023.1222418","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,25]]},"article-number":"1222418"}}